Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

The Health-System Pharmacist’s Role in Providing the Most Effective Treatment for Patients with Hepatorenal Syndrome

Program Overview

This continuing education activity will highlight the health-system pharmacist’s role in providing treatment for patients with hepatorenal syndrome (HRS). The expert faculty will review the science, pathophysiology, and interplay between vasoconstrictor and vasodilator systems on the renal circulation in patients with hepatorenal syndrome type 1. Real-world data for new and emerging therapeutics in hospitalized patients with HRS type ...
View Course
Scientific Updates to Improve Outcomes in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis

Program Overview

This CME activity, derived from content presented at Maui Derm for Dermatologists 2021, will highlight recent advances in the treatment and management of moderate-to-severe atopic dermatitis, particularly in the adult patient population. The expert faculty, Drs. Jonathan Silverberg and Eric Simpson, will first review the immunopathology of atopic dermatitis, as well as current guidelines for both adolescents and ...
View Course
Clinical Updates for the Management of Patients with Pulmonary Arterial Hypertension

Program Overview

This CME program is derived from content presented at the 2020-2021 Eastern Pulmonary Conference Program. The expert faculty, Drs. Sidney S. Braman and James R. Klinger, will discuss the overall approach to treatment of pulmonary arterial hypertension (PAH), considering diagnosis, patient characterization, treatment algorithms and patient response. Topics such as the history of pulmonary arterial hypertension, challenges of ...
View Course
Novel Therapeutic Advances to Improve Outcomes in Patients with Tenosynovial Giant Cell Tumor

Program Overview

This continuing medical education series includes three, 30-minute serialized, educational interviews, designed to bring clinicians up to date on novel therapeutic advances to improve outcomes in patients with tenosynovial giant cell tumor (TGCT). Tenosynovial giant cell tumor is a rare tumor that often leads to severe morbidity or functional limitations. TGCT is categorized into two subtypes, localized and ...
View Course
Managing Hemorrhagic Complications and Bleeding Risks Associated with Platelet P2Y12 Inhibitor Therapy

Program Overview

Antiplatelet therapy is an essential part of secondary prevention of cardiovascular events.  In particular, dual antiplatelet therapy (DAPT) — the combination of aspirin with an oral P2Y12 receptor antagonist — is the predominant approach in patients with acute coronary syndromes (ACS), coronary-artery stenting, or previous myocardial infarction (MI). The three oral P2Y12 receptor antagonists that are in use ...
View Course
Therapeutic Advances for the Management of Pediatric Patients with Atopic Dermatitis

Program Overview

This continuing medical education program is derived from material presented in an AcademicCME-sponsored symposium held in conjunction with the 2020 AAP Virtual National Conference & Exhibition. This continuing medical education program will highlight therapeutic advances for the management of patients with atopic dermatitis, focusing primarily on the pediatric population. The expert faculty, chaired by Dr. Lawrence F. Eichenfield, ...
View Course

Upcoming Events

Alliance 46th Annual Conference

July 14th – 16th, 2021

CCR East Annual Meeting

August 12th-15th, 2021

CCR West Annual Meeting

September 18th – 21st, 2021

2021 Consortium of Multiple Sclerosis Centers Annual Meeting

October 25th – 28th, 2021